Provided by Tiger Trade Technology Pte. Ltd.

Immunocore Holdings plc

36.88
+0.60001.65%
Post-market: 36.880.00000.00%19:30 EDT
Volume:329.45K
Turnover:12.10M
Market Cap:1.90B
PE:-103.42
High:36.98
Open:36.70
Low:35.68
Close:36.28
52wk High:40.71
52wk Low:27.56
Shares:51.50M
Float Shares:45.83M
Volume Ratio:0.70
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3566
EPS(LYR):-0.7054
ROE:-4.47%
ROA:-0.16%
PB:4.52
PE(LYR):-52.28

Loading ...

Immunocore Holdings Price Target Maintained With a $100.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 15

Immunocore to present at Needham Virtual Healthcare Conference fireside chat

Reuters
·
Apr 06

Immunocore to present five-year overall survival data for KIMMTRAK at AACR meeting

Reuters
·
Mar 18

Immunocore Holdings Cut to Hold From Buy by Jefferies

Dow Jones
·
Mar 16

Will Immunocore's (IMCR) 2025 Revenue Growth and Narrower Loss Reshape Its Investment Narrative?

Simply Wall St.
·
Mar 10

Immunocore to present at upcoming investor conferences

Reuters
·
Mar 03

Immunocore Holdings (IMCR) Gets a Hold from Mizuho Securities

TIPRANKS
·
Feb 26

Immunocore Holdings Is Maintained at Buy by Needham

Dow Jones
·
Feb 26

Stock Track | Immunocore Holdings Plummets 5.02% Intraday After Q4 Earnings Miss and Moderating 2026 Growth Outlook

Stock Track
·
Feb 26

Immunocore Holdings plc Publishes Corporate Presentation on Bispecific Soluble TCR Immunotherapies Across Oncology, Infectious Diseases and Autoimmune Disease

Reuters
·
Feb 26

Immunocore Holdings PLC reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 25

UK's Immunocore Q4 KIMMTRAK sales rise 24%

Reuters
·
Feb 25

Immunocore Hldgs Q4 EPS $(0.60) Misses $(0.23) Estimate, Sales $104.478M Miss $107.310M Estimate

Benzinga Earnings
·
Feb 25

Earnings Flash (IMCR) Immunocore Posts Q4 Loss $0.60 a Share

MT Newswires Live
·
Feb 25

Immunocore Q4 net sales rise 24% to USD 104.5 million

Reuters
·
Feb 25

Immunocore - Reports Q4 2025 Diluted Loss per Share $0.60

THOMSON REUTERS
·
Feb 25

Immunocore : Expect Moderating Revenue Growth in 2026

THOMSON REUTERS
·
Feb 25

Immunocore FY EPS USD -0.71 VS. Ibes Estimate USD -0.34

THOMSON REUTERS
·
Feb 25

Immunocore FY Net Income USD -35.514 Million VS. Ibes Estimate USD -18.3 Million

THOMSON REUTERS
·
Feb 25

Immunocore - Kimmtrak Q4 Sales $104.5 Mln, Full Year $400 Mln

THOMSON REUTERS
·
Feb 25